NV reMYND
Records under this name other than patents NV reMYND holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to NV reMYND
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,722,681 | N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases Lapsed on the fee record Ended May 13, 2026 · USPTO record | Lapsed on the fee record | Ended May 13, 2026 | USPTO record |
| US 8,541,406 | Thiadiazole derivatives for the treatment of neurodegenerative diseases Lapsed on the fee record Ended Sep 24, 2025 · USPTO record | Lapsed on the fee record | Ended Sep 24, 2025 | USPTO record |
| US 7,960,556 | Thiadiazole derivatives for the treatment of neuro-degenerative diseases Lapsed on the fee record Ended Jun 14, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 14, 2019 | USPTO record |